相关实验视频

Updated: May 7, 2026

Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration

Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration

Published on: January 20, 2014

通过调节m6AA,Arg-Gly-Asp工程化介质干细胞作为向的纳米疗法来治疗脏纤维化

Xin Zhang¹, Jiaqi Zhao¹, Rui Ge¹

¹Department of Nephrology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China; Clinical Research Center For Kidney Disease, Xuzhou Medical University, Xuzhou, China; Department of Internal Medicine and Diagnostics, Xuzhou Medical University, Xuzhou, China.

Acta biomaterialia

|March 30, 2025

概括

用RGD修改的工程外细胞囊泡 (EVs) 向受损的脏组织,输送miR-126-5p来对抗纤维化. 这种无细胞疗法增强了血管健康,并延迟了慢性病的进展.

科学领域:

生物医学工程生物医学工程
再生医学是一种再生医学.
纳米医学是一种纳米医学.

背景情况:

来自介细胞干细胞 (MSC-EV) 的细胞外囊 (EV) 显示出慢性病 (CKD) 治疗的希望.
诸如非目标效应和低生物可用性等挑战限制了目前MSC-EV的临床使用.
RGD基改造增强了MSC-EV向和治疗潜力.

研究的目的:

开发和评估RGD修改的MSC-EV (RGD-MSC-EV) 进行增强的CKD治疗.
通过m6ARNA甲基化来研究RGD-MSC-EV在缓解纤维化的机制.
评估RGD-MSC-EV在恢复脏微循环和细胞活力的有效性.

主要方法:

使用捐赠细胞辅助膜修饰策略开发了RGD-MSC-EV.
评估了RGD-MSC-EV向,生物分布和治疗疗效在体外和体内.
研究了RNA m6A甲基化通路,包括miR-126-5p传递和ALKBH5-SIRT1调制.

主要成果:

RGD-MSC-EV在脏组织中表现出优越的向,生物分布和保留.
RGD-MSC-EV持续的周毛细血管内皮细胞活力.
释放了miR-126-5p,调节了SIRT1的ALKBH5-介导的m6A,促进了血管生成并恢复了氧气平衡.
在CKD模型中延迟纤维化.

结论:

RGD-MSC-EV提供了一种可行且有效的无细胞策略来治疗脏间歇性纤维化.
恢复m6A修饰和减轻脏PTC损失是关键机制.
这种方法为目前的CKD疗法提供了一个有希望的替代方案.

关键词:

在这里,我们可以看到 EV EV EV EV.这是一种RGD.脏间歇性纤维化脏间歇性纤维化一个SIRT1系统.m6A 一个很好的.

更多相关视频

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting

Published on: June 18, 2018

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models

Published on: May 10, 2022

相关概念视频

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...